⭐ Study Highlights

The two highest-impact studies this week.

Wilhelm F et al. · Lancet Infect Dis. 2026 Apr;26(4):e220-e230 · PMID 40934937 Why it matters: Lancet Infect Dis systematic review of autoantibody evidence in long COVID; advances mechanistic understanding of post-acute sequelae and identifies immunotherapy targets for a condition affecting millions. Post-COVID-19 condition (also known as long COVID) affects a substantial proportion of individuals who have been infected with SARS-CoV-2, profoundly affecting their daily lives and work. Diagnosis and prognosis of long COVID are complex and hindered by heterogeneous symptoms and the absence of validated biomarkers.

2. Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study

Chosidow A et al. · Lancet Infect Dis. 2026 Apr;26(4):374-383 · PMID 41274297 Why it matters: ORIGAMI documents post-COVID resurgence of Mycoplasma pneumoniae in French children across both prospective and retrospective cohort arms; direct antimicrobial stewardship and diagnostic implications. Chikungunya outbreaks have recurred in Brazil since 2014. This multicentre cohort study reports the post-COVID resurgence of Mycoplasma pneumoniae infections in French children, with microbiological confirmation and clinical characterisation across multiple centres.

📑 Index

❤️ Cardiovascular — 22 studies

🔬 Oncology — 18 studies

🏥 Gastroenterology & Surgery — 15 studies

🦠 Infectious Diseases — 13 studies

Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study Chosidow A et al. · Lancet Infect Dis. 2026 Apr;26(4):374-383 · PMID 41274297 Author information: (1)Department of General Paediatrics, Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges, Villeneuve-Saint-Georges, France; GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France. Electronic address: [email protected]. (2)Department of General Paediatrics, Hôpital Clocheville, Tours, France; GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France.

Autoantibodies in long COVID: a systematic review Wilhelm F et al. · Lancet Infect Dis. 2026 Apr;26(4):e220-e230 · PMID 40934937 Post-COVID-19 condition (also known as long COVID) affects a substantial proportion of individuals who have been infected with SARS-CoV-2, profoundly affecting their daily lives and work. Diagnosis and prognosis of long COVID are complex and hindered by heterogeneous symptoms and the absence of validated biomarkers.

🧠 Neurology & Stroke — 11 studies

⚗️ Endocrinology & Metabolism — 8 studies

🫁 Respiratory — 7 studies

💻 AI & Digital Health — 5 studies

💉 Anaesthesia & Pain — 4 studies

🦴 Musculoskeletal & Orthopaedics — 4 studies

👶 Paediatrics — 4 studies

♀️ Women's Health — 4 studies

🌍 Global Health — 3 studies

🦷 Dentistry & Oral Health — 3 studies

🩸 Haematology — 3 studies

👁️ Ophthalmology — 2 studies

🚨 Trauma & Emergency Medicine — 2 studies

🩺 Dermatology — 1 study

🧘 Mental Health — 1 study

🦴 Rheumatology — 1 study

🫘 Urology & Nephrology — 1 study

💊 Pharmacovigilance & Drug Safety — 1 study

📋 Other — 3 studies

Keep Reading